Vertex Pharmaceuticals Incorporated
METHODS OF TREATMENT FOR CYSTIC FIBROSIS

Abstract:

This application describes methods of treating cystic fibrosis or a CFTR mediated disease comprising administering Compound I or a pharmaceutically acceptable salt thereof. (I) The application also describes pharmaceutical compositions comprising Compound I or a pharmaceutically acceptable salt thereof and optionally comprising one or more additional CFTR modulating agents. ##STR00001##